✨ Medicines Classification




13 APRIL NEW ZEALAND GAZETTE 859

Schedule

glibornuride
glimepiride
hemerocallus
hylan polymer
hydroxyephedrine
hydroxyprogesterone
imiglucerase
interleukins
isoamyl nitrite
isobutyl nitrite
isometheptene
isopropamide; except for dermal use
khellin
laudexium
leflunomide
lepidin
leptazol
levocabastine; except for nasal or ophthalmic use
lidoflazine
lindane; except in medicines for external use containing 2% or less
liothyronine
loratadine; except for oral use
luteinising hormone
mangafodipir
mefenorex
megestrol
mepacrine
mephenisin
mometasone; except when specified elsewhere in the Schedule

naratriptan
nicotine; for nasal administration except when sold from a smoking cessation clinic run under the auspices of a registered medical practitioner; in medicines other than for smoking cessation
nikethamide
noradrenaline
normethandrone
octyl nitrite
oestriol
oleander
oleandrin
orthopterin
oseltamivir
palivizumab
pamaquine
penciclovir; except for the topical treatment of herpes labialis
pentamethonium
phenazone; except for external use
phenylephrine; except when specified elsewhere in the Schedule
pilocarpine; except in medicines containing 0.025% or less
potassium perchlorate
practolol
pramipexole
procyclidine; except in medicines for dermal use containing 5% or less progesterone
propylhexedrine
pseudoephedrine; except when specified elsewhere in the Schedule

quinpristin
rabeprazole
reboxetine
repaglinide
rofecoxib
rosiglitazone
sodium phosphate; in oral laxative preparations
solasadine
sontoquine
stilboestrol
strophanthin-k
strophanthus
tanacetum vulgare; in medicines containing more than 0.8% of oil of tansy
telmisartan
thevetia
thevetin
thyroid
tirofiban
tolfenamic acid
troglitazone
tulobuterol
visnadine
yohimbine
zafirlukast
zanamivir
ziprasidone

Schedule 2

Restricted Medicines

adrenaline; in medicines containing 1% or less and more than 0.02%
chlorbutol; in medicines containing more than 5%
fluticasone; in aqueous nasal sprays delivering up to 50 micrograms per actuation when the maximum recommended daily dose is no greater than 200 micrograms
glucagon
mometasone; in aqueous nasal sprays delivering up to 50 micrograms per actuation when the maximum recommended daily dose is no greater than 200 micrograms
nicotine; for inhalation or in sublingual tablets except when sold from a smoking cessation clinic run under the auspices of a registered medical practitioner, nurse, pharmacist or psychologist
sodium phosphate; in oral bowel preparations for bowel cleansing prior to diagnostic, medical or surgical procedures

Schedule 3

Pharmacy-only Medicines

cetirizine; for oral use
chlorbutol; in medicines containing 5% or less and more than 0.5%
fexofenadine; for oral use
ibuprofen; in solid dose form containing 200 milligrams or less per dose form and in packs containing not more than 100 tablets or capsules
isopropamide; for dermal use
levocabastine; for nasal or ophthalmic use
lindane; in medicines for external use containing 2% or less
lobelia; except in medicines for smoking or burning
loratadine; for oral use



Next Page →



Online Sources for this page:

VUW Te Waharoa PDF NZ Gazette 2000, No 39


Gazette.govt.nz PDF NZ Gazette 2000, No 39





✨ LLM interpretation of page content

πŸ₯ Classification of Medicines (continued from previous page)

πŸ₯ Health & Social Welfare
Medicines Act 1981, Prescription Medicines, Restricted Medicines, Pharmacy-Only Medicines, Classification